NNNN MEXC RealStocks
Own real NNNN shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-15 07:48:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Anbio Biotechnology (NNNN) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $3.90, with a market capitalization of $167.66M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.09 to $44.73. This page covers its latest market performance, valuation, price trends and company information.
$167.66M | |
$3.82 | |
$4.05 | |
$3.70 | |
$3.80 | |
21.23K | |
131.73K | |
-- | |
$44.73 | |
$3.09 | |
-- | |
-- |
Anbio Biotechnology (NNNN) last closed at $3.90 as of 2026-11-13 21:23:00, up 0.79% ($0.03) from the previous close of $3.80.
During the latest regular trading session, NNNN traded between $3.70 and $4.05, with a volume of 21.23K shares. The closing price was near the middle and near the lower end of its 52-week range.
Over the past seven days, Anbio Biotechnology (NNNN) moved from $3.59 to $3.90, representing a gain of 8.64% ($0.31).
The stock traded between $3.38 and $4.43 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.
The average daily volume was 39.87 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 1.9%
NNNN is currently trading at $3.90, placing it 1.9% of the way from its 52-week low of $3.09 to its 52-week high of $44.73. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).
| Employees | 27 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Anbio Biotechnology (NNNN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to NNNN, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between NNNN shares and USD.
NNNN Shares to USD
1.00 NNNN shares = 3.9 USD
Calculations are estimates based on the latest available price and are for reference only.